Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Cellectar Biosciences Inc., 3 years.
Cellectar Biosciences Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cellectar Biosciences Inc. July 7, 202698.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | MaxCyte Inc. | Open-market sale | −10,142 | $0.82 | $8,316 |
| Aug 13, 2025 | MaxCyte Inc. | Open-market purchase | +50,000 | $1.29 | $64,500 |
| Mar 18, 2025 | MaxCyte Inc. | Open-market sale | −6,939 | $3.18 | $22,066 |
| Mar 14, 2025 | MaxCyte Inc. | Grant or award | +37,500 | — | — |
| Mar 15, 2024 | MaxCyte Inc. | Grant or award | +81,250 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.